In ovarian cancer cells with the 185delAG founder mutation in the breast cancer susceptibility gene 1, there was an increase in active IL‐1 and elevation in caspase 1 cleavage mediated by inflammasome.211. This evidence concerns the gene IL1A and ovarian cancer.